What is Infina Finance and why is Kotak selling the stake?

Infina Finance is an investment platform historically linked to the Kotak group and marquee investors. KMCC will sell 30.99% for Rs 1,293.91 crore, cutting group ownership to 19%. The move frees capital, simplifies reporting by removing an associate, and supports focus on core banking.

How could the Kotak Mahindra Bank stake sale affect earnings?

The sale should add a modest one-off gain to March-quarter profit and slightly improve return ratios. It also removes associate-related volatility from consolidated accounts. The bigger test is how quickly freed capital is redeployed into profitable lending without raising credit risk.

Who are the buyers and why does it matter?

Buyers include Uday Kotak KF Trust and Rakesh Jhunjhunwala trusts, according to reports. Their interest signals confidence in the platform and the bank’s direction. For investors, notable insider and marquee participation reduces uncertainty and supports sentiment around capital allocation decisions.

What should Australian investors watch next?

Track deal closing by 31 March, the disclosed gain-on-sale, and April 25 results. Watch loan growth, NIMs, and asset quality, plus any guidance on capital deployment. Also monitor AUD/INR moves, as currency swings affect local returns from India-focused funds and ETFs.

Global Market Insights

KOTAKBANK.NS Stock Today, March 22: Infina Stake Sale Frees Capital

ByHuzaifa Zahoor March 22, 2026March 22, 2026

Kotak Mahindra Bank stake sale headlines today as the group moves to free capital before quarter-end. KMCC will sell 30.99% of Infina Finance for Rs 1,293.91 crore, dropping group ownership to 19% and declassifying Infina as an associate. For AU investors tracking India exposure, this could lift March-quarter earnings modestly and improve capital ratios. KOTAKBANK.NS ended flat last session, but technicals sit in oversold territory. We explain the Infina Finance stake sale, near-term earnings effects, and key levels to watch into the April results.